Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Structure (London, England : 1993)|November 12, 2013
The structural motifs for substrate binding and dimerization of the α subunit of collagen prolyl 4-hydroxylaseJothi Anantharajan, M Kristian Koski, Petri Kursula, et al.
Journal of Computer-Aided Molecular Design|April 24, 2025
Structure-based discovery of novel non-covalent small molecule inhibitors of USP30Padmanabhan Anbazhagan, Jothi Anantharajan, Justina Fulwood, et al.
The Biochemical Journal|January 18, 2017
Assembly of the elongated collagen prolyl 4-hydroxylase α2β2 heterotetramer around a central α2 dimerM Kristian Koski, Jothi Anantharajan, Petri Kursula, et al.
Protein Science : a Publication of the Protein Society|September 1, 2018
Structural enzymology binding studies of the peptide-substrate-binding domain of human collagen prolyl 4-hydroxylase (type-II): High affinity peptides have a PxGP sequence motifAbhinandan V Murthy, Ramita Sulu, M Kristian Koski, et al.
Biochemical and Biophysical Research Communications|November 18, 2023
Identification and characterization of inhibitors covalently modifying catalytic cysteine of UBE2T and blocking ubiquitin transferJothi Anantharajan, Qian Wen Tan, Justina Fulwood, et al.
Protein Science : a Publication of the Protein Society|February 15, 2024
Identification of small-molecule binding sites of a ubiquitin-conjugating enzyme-UBE2T through fragment-based screeningYong Yao Loh, Jothi Anantharajan, Qiwei Huang, et al.
Angewandte Chemie (International Ed. in English)|May 19, 2021
Strategic Design of Catalytic Lysine-Targeting Reversible Covalent BCR-ABL Inhibitors*David Quach, Guanghui Tang, Jothi Anantharajan, et al.
Protein Science : a Publication of the Protein Society|November 11, 2021
Structure-activity relationship studies of allosteric inhibitors of EYA2 tyrosine phosphataseJothi Anantharajan, Nithya Baburajendran, Grace Lin, et al.
Bioorganic & Medicinal Chemistry|October 2, 2021
Fragment-based lead discovery of indazole-based compounds as AXL kinase inhibitorsPearly Shuyi Ng, Klement Foo, Sandra Sim, et al.
Molecular Cancer Therapeutics|July 10, 2019
Structural and Functional Analyses of an Allosteric EYA2 Phosphatase Inhibitor That Has On-Target Effects in Human Lung Cancer CellsJothi Anantharajan, Hengbo Zhou, Lingdi Zhang, et al.
Pageof 1